Last reviewed · How we verify
tiotropium bromide 18mcg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
tiotropium bromide 18mcg (tiotropium bromide 18mcg) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| tiotropium bromide 18mcg TARGET | tiotropium bromide 18mcg | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- tiotropium bromide 18mcg CI watch — RSS
- tiotropium bromide 18mcg CI watch — Atom
- tiotropium bromide 18mcg CI watch — JSON
- tiotropium bromide 18mcg alone — RSS
Cite this brief
Drug Landscape (2026). tiotropium bromide 18mcg — Competitive Intelligence Brief. https://druglandscape.com/ci/tiotropium-bromide-18mcg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab